May 12, 2008 - Draeger Medical Systems Inc., said last week it has received 510(k) clearance from the FDA to market the Carina, its latest product in its ventilator product line to the U.S. market.
The Carina ventilator offers both invasive and noninvasive capabilities in one device. Its latest technology known as “Synch Plus” will compensate for leakage and provide effective breath delivery, Draeger said. The Carina is well suited for the emergency room, general ward, ICU, or sub-acute facilities as it features an internal battery and can operate independent of a high-pressure gas system, the manufacturer said.
The transportability of the Carina makes patient transfer seamless and expedient, especially when a patient requires noninvasive support, the company said.
For patients who are mechanically ventilated long term, the Carina-home facilitates similar style ventilation technology for chronic patients outside of the hospital. The Carina-home has been in the U.S. marketplace for over a year.
The Carina is expected to be commercially available by July 2008 in the U.S.
For more information: www.draeger.com